Stomach Cancer Trial, Recruiting NCT06768463 Sponsor: University Medical Center Ho Chi Minh City (UMC) Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06768463
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 75 years old
  • People who have gastric cancer that has spread to the lining of the abdomen (peritoneum), confirmed by tissue or fluid testing during surgical exploration
  • People whose cancer spread to the abdominal lining is limited (classified as P1 or P2 according to a specific gastric cancer staging system)
  • People with liver spread where the largest affected area measures 5 cm or smaller
  • People with certain lymph node spread in the area around the major abdominal blood vessel (the aorta), in a specific region between two named points, where the affected lymph nodes are at least 1 cm in size
  • People who have ovarian tumours caused by the spread of gastric cancer (called Krukenberg tumours), in one or both ovaries — this counts as one site of spread
  • People who have spread to no more than two sites in the body
  • People who are in good general health and able to carry out daily activities without limitation (confirmed with trial site)
  • People whose blood test results show the bone marrow, liver, and kidneys are working well enough to safely participate
  • People whose expected survival is greater than 3 months
  • People who are able to receive nutrition through a feeding tube and have the mental capacity to give informed consent
  • People who have already completed 4 cycles of standard first-line systemic (whole-body) treatment for their cancer
  • People for whom a repeat keyhole (laparoscopic) procedure after first-line treatment has shown that surgery to remove the cancer appears feasible
  • People whose scans show no cancer spread to areas outside the abdomen (such as the lungs or bones)
  • People whose scans show the abdominal lining disease has not grown or spread further since starting treatment
  • People with a specific cancer spread score (called PCI) below 12
  • People where only cancer cells in fluid are found, without visible spread on the abdominal lining, may still be considered
  • People for whom surgeons believe there is a reasonable chance of removing all visible cancer with clear edges (called R0 resection)
  • People for whom an appropriate level of lymph node removal during surgery is considered feasible

Who may not be able to join:

  • People who have or develop cancer spread to areas outside the abdomen (such as lungs or bones) at any point
  • People who have had another cancer diagnosed in the last 5 years, except for a specific type of non-melanoma skin cancer (basal cell carcinoma) or very early-stage cervical changes
  • People of reproductive age who are not willing to use adequate contraception during the trial
  • People with significant other health conditions that, in the opinion of the trial doctor, would make participation unsafe or unsuitable
  • People with uncontrolled ongoing or active infections, heart failure, unstable chest pain, or irregular heart rhythm
  • People with mental health conditions or personal circumstances that would make it difficult to follow the trial requirements
  • People who are pregnant or breastfeeding
  • People who have previously had surgery to remove part of the stomach for gastric cancer
  • People whose cancer got worse — either on scans or based on symptoms — while receiving first-line treatment (including worsening fluid build-up in the abdomen that required medical procedures, or caused significant symptoms)
  • People whose cancer is judged to be too extensive to remove safely, including those with a PCI score above 12, large sections of bowel involved, cancer in certain parts of the pancreas or bile ducts, cancer in a specific area near the liver called the hepatoduodenal ligament, cancer wrapped around major blood vessels, or cancer spread into the food pipe (oesophagus) in a way that makes complete removal unlikely
  • People who choose to withdraw from the study at any time
  • People for whom the trial doctor decides it is in their best interest to stop participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +84918133915

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Medical Center Ho Chi Minh City (UMC)
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
10 July 2027

Where this trial is recruiting

🇻🇳 Vietnam

Primary endpoints

Median survival time; Progression-free survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov